Anlon Healthcare

50
Hold
  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE0Y8W01025
  • NSEID: AHCL
  • BSEID: 544497
INR
25.14
2.24 (9.78%)
BSENSE

Sep 21, 12:17 PM

BSE+NSE Vol: 7.31 cr

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationProfit and Loss Results
Results Snapshot
Figures in Cr
Standalone - Profit And Loss Results
Mar'26
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Profit And Loss Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Mar 2026 is 46.73% vs 80.65% in Mar 2025

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Mar 2026 is 43.25% vs 108.32% in Mar 2025

stock-summary

Interest

YoY Growth in year ended Mar 2026 is 17.16% vs -5.48% in Mar 2025

stock-summary

Profit After Tax

YoY Growth in year ended Mar 2026 is 35.53% vs 112.47% in Mar 2025

Compare Profit and Loss Results of Anlon Healthcare
Markets Mojo
Figures in Cr
standalone - Profit And Loss Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
No of Months
12
12
Operating Income
176.00
623.00
-447.00
-71.75%
Less :Inter divisional transfers
0.00
0.00
0.00
0%
Less: Excise
0.00
0.00
0.00
0%
Net Sales
176.00
623.00
-447.00
-71.75%
Expenditure (Ex Depriciation)
Stock Adjustments
-16.00
8.00
-24.00
-300.00%
Raw Materials Consumed
129.00
282.00
-153.00
-54.26%
Power & Fuel Cost
3.00
11.00
-8.00
-72.73%
Employee Cost
5.00
112.00
-107.00
-95.54%
Operating Expenses
3.00
27.00
-24.00
-88.89%
General and Administration Expenses
-1.00
-1.00
0.00
0.00%
Selling and Distribution Expenses
0.00
28.00
-28.00
-100.00%
Cost of Software developments
0.00
0.00
0.00
0%
Miscellaneous Expenses
2.00
3.00
-1.00
-33.33%
Expenses Capitalised
0.00
0.00
0.00
0%
Total Expenditure
130.00
521.00
-391.00
-75.05%
Operating Profit (PBDIT) excl Other Income
46.00
101.00
-55.00
-54.46%
Other Income
0.00
22.00
-22.00
-100.00%
Operating Profit (PBDIT)
46.00
123.00
-77.00
-62.60%
Interest
4.00
1.00
3.00
300.00%
Profit before Depriciation and Tax
42.00
122.00
-80.00
-65.57%
Depreciation
1.00
12.00
-11.00
-91.67%
Profit Before Taxation & Exceptional Items
40.00
109.00
-69.00
-63.30%
Exceptional Income / Expenses
0.00
0.00
0.00
0%
Profit Before Tax
40.00
109.00
-69.00
-63.30%
Provision for Tax
12.00
26.00
-14.00
-53.85%
Profit After Tax
27.00
82.00
-55.00
-67.07%
Extraordinary Items
0.00
0.00
0.00
0%
Adj to Profit After Tax
0.00
0.00
0.00
0%
Profit Balance B/F
23.00
507.00
-484.00
-95.46%
Profit Available for appropriations
50.00
589.00
-539.00
-91.51%
Appropriations
50.00
589.00
-539.00
-91.51%
Equity Dividend (%)
0%
18%
-18.00
Earnings Per Share
5.84
41.11
-35.27
-85.79%
Profit And Loss - Net Sales
Net Sales 176.50 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 46.73% vs 80.65% in Mar 2025

Profit And Loss - Operating Profit (PBDIT)
Operating Profit (PBDIT) 46.14 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 43.25% vs 108.32% in Mar 2025

Profit And Loss - Interest
Interest 4.35 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 17.16% vs -5.48% in Mar 2025

Profit And Loss - Profit After Tax
Profit After Tax 27.81 Cr
in Mar 2026

Figures in Cr
stock-summary

YoY Growth in year ended Mar 2026 is 35.53% vs 112.47% in Mar 2025